What is NDC 66993-233?

66993-233 is the product NDC for Dasatinib, Dasatinib 20 mg/1 tablet, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.

Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dasatinib?

95 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dasatinib NDC 66993-233 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)66993-233Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66993-0233Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66993-233-60	6699302336066993023360	1 BOTTLE in 1 CARTON (66993-233-60) / 60 TABLET in 1 BOTTLEMarketed from Sep 3, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dasatinib
Generic name (nonproprietary): dasatinib
Active ingredients: Dasatinib — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Prasco LaboratoriesNDC labeler code 66993
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 021986
Marketing start: Sep 3, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Protein Kinase Inhibitors (Mechanism)
Identifiers: Product ID 66993-233_19048218-75dd-45fc-8e6e-fc660d861fb7SPL ID 19048218-75dd-45fc-8e6e-fc660d861fb7SPL set ID 1931e73f-918c-4d69-9543-de9643513d05RxCUI 643105, 643107, 643109, 799047, 1045402, 1045406UNII RBZ1571X5H
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466993023360 followed by a unit qualifier and the quantity

Package 66993-0233-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 9, 2024.

Indications (excerpt from the label)

Dasatinib tablets are indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasatinib tablets are indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase. newly diagnosed Ph+ ALL in combination with chemotherapy. Dasatinib tablets are a kinase inhibitor indicated for the treatment of newly diagno…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 66993-233

What is NDC 66993-233?: 66993-233 is the product NDC for Dasatinib, Dasatinib 20 mg/1 tablet, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dasatinib.
What is the active ingredient?: Dasatinib.
Who is the labeler?: Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dasatinib?: 95 other product NDCs are listed under this name. See all Dasatinib NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dasatinib NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dasatinib	Dasatinib 20 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-192	82009-0192-60
Dasatinib	Dasatinib 100 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-196	82009-0196-30
Dasatinib	Dasatinib 50 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-193	82009-0193-60
Dasatinib	Dasatinib 70 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-194	82009-0194-60
Dasatinib	Dasatinib 80 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-195	82009-0195-30
Dasatinib	Dasatinib 140 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-197	82009-0197-30
Dasatinib	Dasatinib 20 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-319	72205-0319-60
Dasatinib	Dasatinib 100 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-323	72205-0323-30
Dasatinib	Dasatinib 50 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-320	72205-0320-60
Dasatinib	Dasatinib 70 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-321	72205-0321-60

All 96 Dasatinib NDCs

Other NDCs under NDA 021986

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021986
Product	Strength	Form · route	Labeler	Product NDC
Dasatinib	Dasatinib 50 mg/1	TabletOral	Prasco Laboratories	66993-234
Dasatinib	Dasatinib 70 mg/1	TabletOral	Prasco Laboratories	66993-235
Dasatinib	Dasatinib 80 mg/1	TabletOral	Prasco Laboratories	66993-236
Dasatinib	Dasatinib 100 mg/1	TabletOral	Prasco Laboratories	66993-237
Dasatinib	Dasatinib 140 mg/1	TabletOral	Prasco Laboratories	66993-238
Spryceldasatinib	Dasatinib 70 mg/1	TabletOral	E.R. Squibb & Sons, L.L.C.	0003-0524
Spryceldasatinib	Dasatinib 20 mg/1	TabletOral	E.R. Squibb & Sons, L.L.C.	0003-0527
Spryceldasatinib	Dasatinib 50 mg/1	TabletOral	E.R. Squibb & Sons, L.L.C.	0003-0528
Spryceldasatinib	Dasatinib 100 mg/1	TabletOral	E.R. Squibb & Sons, L.L.C.	0003-0852
Spryceldasatinib	Dasatinib 80 mg/1	TabletOral	E.R. Squibb & Sons, L.L.C.	0003-0855
Spryceldasatinib	Dasatinib 140 mg/1	TabletOral	E.R. Squibb & Sons, L.L.C.	0003-0857